N-4-Hydroxyphenylretinamide Enhances Retinoic Acid-Induced Differentiation and Retinoylation of Proteins in the Human Acute Promyelocytic Leukemia Cell Line, NB4, by a Mechanism That May Involve Inhibition of Retinoic Acid Catabolism

This publication has 26 references indexed in Scilit:

• Comparative activity of N-(4-hydroxyphenyl)-all-trans-retinamide and α-difluoromethylornithine as inhibitors of lymphoma induction in PIM transgenic mice
  Carcinogenesis: Integrative Cancer Research, 1996
• Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase
  Blood, 1996
• N-(4-hydroxyphenyl)retinamide: interactions with retinoid-binding proteins/receptors
  Carcinogenesis: Integrative Cancer Research, 1995
• N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma
  Carcinogenesis: Integrative Cancer Research, 1995
• Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia
  Biochemical Pharmacology, 1995
• Modulation of all-trans retinoic acid pharmacokinetics by liarozole
  Cancer Chemotherapy and Pharmacology, 1994
• N‐(4‐hydroxyphenyl) retinamide induces cell cycle specific growth inhibition in PC3 cells
  The Prostate, 1994
• The synthetic retinoid (4‐hydroxyphenyl)retinamide decreases collagen expression in vitro and in the tight‐skin mouse
  Arthritis & Rheumatism, 1993
• Therapeutic effect of N-(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea-induced rat mammary cancer
  Cancer Letters, 1989
• Effect of 13‐cis‐retinoic acid and 4‐hydroxyphenyl‐all‐trans‐retinamide on human tumor colony formation in soft agar
  International Journal of Cancer, 1983